# EUropean Pharmacogenetics of AntiCoagulant Therapy - Warfarin

Study · id `cardio:ct-nct01119300` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01119300](<https://clinicaltrials.gov/study/NCT01119300>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01119300

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 455 participants.

## Technical summary

Registry record NCT01119300. Randomized; single masking. Start 2011-01 (registry gives no type); primary completion 2013-10 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking
- Phase: Phase 4
- Enrolled: 455 participants (enrolled count; ClinicalTrials.gov record NCT01119300, source copy `cardio:ctgov-nct01119300-2014-12-03`, retrieved 2026-10-26)
- Start date: 2011-01 (registry gives no type) (ClinicalTrials.gov record NCT01119300, source copy `cardio:ctgov-nct01119300-2014-12-03`, retrieved 2026-10-26)
- Primary completion: 2013-10 (actual) (ClinicalTrials.gov record NCT01119300, source copy `cardio:ctgov-nct01119300-2014-12-03`, retrieved 2026-10-26)
- Completion: 2013-10 (actual) (ClinicalTrials.gov record NCT01119300, source copy `cardio:ctgov-nct01119300-2014-12-03`, retrieved 2026-10-26)
- Countries: Sweden; United Kingdom (ClinicalTrials.gov record NCT01119300, source copy `cardio:ctgov-nct01119300-2014-12-03`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01119300-2014-12-03`, retrieved 2026-10-26)

## The registry's words

- Brief title: EUropean Pharmacogenetics of AntiCoagulant Therapy - Warfarin
- Acronym: EU-PACT
- Condition: Venous Thromboembolism
- Condition: Atrial Fibrillation
- Intervention (Other): Genotype-guided dosing algorithm
- Intervention (Other): Standard care
- Lead sponsor: Utrecht Institute for Pharmaceutical Sciences
- Lead sponsor class: OTHER
- Collaborator: Utrecht University
- Collaborator class: OTHER
- Collaborator: Leiden University Medical Center
- Collaborator class: OTHER
- Collaborator: Erasmus Medical Center
- Collaborator class: OTHER
- Collaborator: University of Ulm
- Collaborator class: OTHER
- Collaborator: Newcastle University
- Collaborator class: OTHER
- Collaborator: University of Liverpool
- Collaborator class: OTHER
- Collaborator: LGC Limited
- Collaborator class: INDUSTRY
- Collaborator: Uppsala University
- Collaborator class: OTHER
- Collaborator: Democritus University of Thrace
- Collaborator class: OTHER
- Collaborator: Elisabethinen Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)

### Main results

- Registry lists this paper as a reference of type result; PubMed types it as a trial report that names this trial and no other, dated on or after the trial start, and its title marks no secondary, follow-up or other further analysis: A randomized trial of genotype-guided dosing of warfarin (`cardio:pubmed-24251363`)

Courtesy of the U.S. National Library of Medicine.

## Registry records

Records a program assembled from a public registry; no person wrote or checked them. They are counted here, not listed: the JSON record of this page lists each one in its relationships.

- 11 registry organizations

## Provenance

Content hash: ec6841e30384b2d54c32a1cb97bcb1ae4ef3a0cf58e519c584654c502b3ee412
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
